Notice of Closed Meeting, 55817-55818 [2022-19570]
Download as PDF
<![CDATA[
55817
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Microbiologist (IP) .............................
Healthcare Personnel Safety Monthly Reporting Plan—completed by
Dialysis Facilities.
Healthcare Personnel Safety Monthly Reporting Plan—completed by
Inpatient Psychiatric Facilities.
COVID–19 Dialysis Component
Form.
NHSN COVID–19 Hospital Module
NHSN COVID–19 Hospital Module
Microbiologist (IP) .............................
Microbiologist (IP) .............................
Hospitals ...........................................
Infusion Centers and Outpatient
Clinics reporting Inventory & use
of therapeutics (MABs).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–19562 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund Addis
Ababa City Administration Health
Bureau of Ethiopia
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000 for
Year 1 of funding to the Addis Ababa
City Administration Health Bureau of
Ethiopia (AACAHB) to ensure
continuity of quality comprehensive
HIV/AIDS prevention, care, and
treatment services for controlling the
HIV epidemic activities in Addis Ababa
City Administration of Ethiopia. The
award will help the city close gaps to
achieve the 95–95–95 goals (95% of
HIV-positive individuals knowing their
status, 95% of those receiving ART
[Antiretroviral therapy], and 95% of
those achieving viral suppression) and
reach HIV epidemic control. Funding
amounts for years 2–5 will be set at
continuation.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
The period for this award will be
September 30, 2022 through September
29, 2027.
DATES:
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
5/60
5,775
394
12
5/60
394
4,900
104
20/60
169,867
6,000
400
365
52
90/60
15/60
3,285,000
5,200
Summary of the Award
Recipient: Addis Ababa City
Administration Health Bureau of
Ethiopia.
Purpose of the Award: The purpose of
this award is to ensure continuity of
quality comprehensive HIV/AIDS
prevention, care, and treatment services
for controlling the HIV epidemic
activities in Addis Ababa City
Administration of Ethiopia. This NOFO
will help the city close gaps to achieve
the 95–95–95 goals and reach HIV
epidemic control.
Amount of Award: The approximate
year 1 funding amount will be
$10,000,000 in Federal Fiscal Year
(FFY) 2022 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Period of Performance: September 30,
2022 through September 29, 2027.
Fmt 4703
Sfmt 4703
Total
burden
hours
9
Tesfaye Desta, Center for Global Health,
Centers for Disease Control and
Prevention, U.S. Embassy—Addis
Ababa, Entoto Road, Addis Ababa,
Ethiopia, Telephone: 800–232–6348,
Email: hmz4@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will implement
prevention, testing and counselling,
prevention of mother to child
transmission, care and treatment,
laboratory, Strategic Information (M&E,
Surveillance, HIS), TB/HIV and other
public health need affecting HIV/AIDS
programming like COVID in the capital
city of Ethiopia, Addis Ababa.
The purpose of this award is to
continue supporting the strengthening
of public health response and programs,
including but not limited to HIV/AIDS,
in the Addis Ababa City. AACAHB is
the only government entity with a legal
authority and mandate to plan, manage,
administer, and coordinate all healthrelated activities in the city.
Frm 00039
Average
burden per
response
(in hours)
7,700
FOR FURTHER INFORMATION CONTACT:
PO 00000
Number of
responses per
respondent
Authority: Public Law 108–25 (the
United States Leadership Against HIV
AIDS, Tuberculosis and Malaria Act of
2003).
Dated: September 6, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–19566 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
RFA–OH–22–003, Occupational Safety
and Health Training Project Grants
(TPG).
Date: December 6, 2022.
Time: 1:00 p.m.–4:00 p.m., EST.
E:\FR\FM\12SEN1.SGM
12SEN1
55818
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Officer, Office of
Extramural Programs, National Institute
for Occupational Safety and Health,
CDC, 1095 Willowdale Road,
Morgantown, West Virginia 26505;
Telephone: (304) 285–5879; Email:
MRidenour@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–19570 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–22CR]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Homeless
Service Providers’ Knowledge,
Attitudes, and Practices Regarding Body
Lice, Fleas and Associated Diseases’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on February 22, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Homeless service providers
knowledge, attitudes, and practices
regarding body lice, fleas and associated
diseases—New—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Several bacterial vector-borne
diseases that are spread by body lice
and fleas disproportionately affect
persons experiencing homelessness
(PEH). Given the potential severity of
louse- and flea-borne diseases, as well
as their disproportionate impact on
PEH, understanding the knowledge, and
gaps in knowledge, of urban homeless
service providers will allow for targeted
education and interventions to reduce
the risk of louse- and flea-borne disease
among this population.
This information collection aims to
improve CDC’s understanding of
homeless service providers knowledge,
attitudes, and practices regarding
vector-borne diseases that can affect
PEH. Insights gained from this
information collection will be used to
develop guidance for control of vectorborne diseases among PEH, and to
improve educational outreach regarding
these diseases.
Homeless service providers who work
or volunteer in shelters serving PEH and
homeless service providers who work
on outreach teams serving unhoused
persons living on the street or in
encampments will serve as respondents
for this study. Participating local or state
public health partners will recruit up to
10 homeless service sites or outreach
organizations. At each participating
service site or outreach organization, 3–
5 participants will be recruited to
participate, with a goal of 30–50
participants recruited by each local or
state public health partner. A total of
240–500 participants will complete a
survey instrument. In addition, one
participant from each homeless service
site or outreach organization will
complete a separate site assessment
form regarding policies and services to
better understand structural barriers to
vector-borne disease prevention,
diagnosis, and treatment.
CDC requests OMB approval for an
estimated 320 annual burden hours.
There is no cost to respondents other
than their time to participate.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Homeless Service Providers—Shelter
workers and volunteers.
Knowledge, Attitudes, and Practices about Body
Lice- and Flea-borne Diseases: Survey for Shelter Workers.
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\12SEN1.SGM
200
12SEN1
Number of
responses per
respondent
(in hours)
1
Average
burden per
response
(in hours)
45/60
]]>Agencies
[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55817-55818]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19570]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-RFA-OH-22-003, Occupational Safety
and Health Training Project Grants (TPG).
Date: December 6, 2022.
Time: 1:00 p.m.-4:00 p.m., EST.
[[Page 55818]]
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Marilyn Ridenour, B.S.N., M.P.H.,
Scientific Review Officer, Office of Extramural Programs, National
Institute for Occupational Safety and Health, CDC, 1095 Willowdale
Road, Morgantown, West Virginia 26505; Telephone: (304) 285-5879;
Email: [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-19570 Filed 9-9-22; 8:45 am]
BILLING CODE 4163-18-P
